Immunotherapy for pediatric brain tumors: past and present

被引：30

作者：

Foster, Jessica B. ^{[1
,2
]}

Madsen, Peter J. ^{[3
]}

Hegde, Meenakshi ^{[4
,5
]}

Ahmed, Nabil ^{[4
,5
]}

Cole, Kristina A. ^{[1
,2
]}

Maris, John M. ^{[1
,6
]}

Resnick, Adam C. ^{[3
,7
]}

Storm, Phillip B. ^{[3
,7
]}

Waanders, Angela J. ^{[8
]}

机构：

[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA

[3] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA

[4] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[5] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[6] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA

[7] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA

[8] Ann & Robert H Lurie Childrens Hosp Chicago, Div Oncol, Chicago, IL 60611 USA

来源：

NEURO-ONCOLOGY | 2019年 / 21卷 / 10期

关键词：

brain tumor; immunotherapy; pediatric; ACTIVATED KILLER-CELLS; WT1 PEPTIDE VACCINATION; MALIGNANT PRIMARY BRAIN; T-CELLS; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PEPTIDES; HEMATOLOGICAL MALIGNANCIES; IMMUNE-RESPONSES; YOUNG-ADULTS; GLIOBLASTOMA;

D O I：

10.1093/neuonc/noz077

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The field of cancer immunotherapy has progressed at an accelerated rate over the past decade. Pediatric brain tumors thus far have presented a formidable challenge for immunotherapy development, given their typically low mutational burden, location behind the blood-brain barrier in a unique tumor microenvironment, and intratumoral heterogeneity. Despite these challenges, recent developments in the field have resulted in exciting preclinical evidence for various immunotherapies and multiple clinical trials. This work reviews the history and advances in active immunotherapy, checkpoint blockade, and adoptive T-cell therapy for pediatric brain tumors, including ongoing clinical trials.

引用

页码：1226 / 1238

页数：13

共 50 条

[31] Checkpoint Proteins in Pediatric Brain and Extracranial Solid Tumors: Opportunities for Immunotherapy
Ring, Eric K.
Markert, James M.
Gillespie, G. Yancey
Friedman, Gregory K.
CLINICAL CANCER RESEARCH, 2017, 23 (02) : 342 - 350
[32] Immunotherapy in brain tumors
De Carli, Emilie
Delion, Matthieu
Rousseau, Audrey
ANNALES DE PATHOLOGIE, 2017, 37 (01) : 117 - 126
[33] Immunotherapy for Brain Tumors
Sampson, John H.
Maus, Marcela V.
June, Carl H.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (21) : 2450 - +
[34] Immunotherapy for Brain Tumors
Hoang-Minh, Lan B.
Mitchell, Duane A.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (11)
[35] Immunotherapy of Brain Tumors
Dutoit, Valerie
Migliorini, Denis
Walker, Paul R.
Dietrich, Pierre-Yves
IMMUNO-ONCOLOGY, 2015, 42 : 11 - 21
[36] Immunotherapy for Brain Tumors
Lan B. Hoang-Minh
Duane A. Mitchell
Current Treatment Options in Oncology, 2018, 19
[37] PEDIATRIC CARDIOLOGY - PAST AND PRESENT
LINDINGER, A
MEDIZINISCHE WELT, 1991, 42 (02): : 107 - 115
[38] CAR-T cells for pediatric brain tumors: Present and future
Leruste, Amaury
Beccaria, Kevin
Doz, Francois
BULLETIN DU CANCER, 2021, 108 (10) : S109 - S116
[39] "Present and future of immunotherapy in Neuroendocrine Tumors"
Manuela Albertelli
Andrea Dotto
Federica Nista
Alessandro Veresani
Luca Patti
Stefano Gay
Stefania Sciallero
Mara Boschetti
Diego Ferone
Reviews in Endocrine and Metabolic Disorders, 2021, 22 : 615 - 636
[40] The past, present and future of Gamma Knife radiosurgery for brain tumors: the Pittsburgh experience
Monaco, Edward A., III
Grandhi, Ramesh
Niranjan, Ajay
Lunsford, L. Dade
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 437 - 445

← 1 2 3 4 5 →